Literature DB >> 3994934

The role of cytoreductive surgery in advanced carcinoma of the ovary: an analysis of primary and second surgery.

E Wiltshaw, K S Raju, I Dawson.   

Abstract

Second operations were performed as part of planned management in 53 patients 5-7 months after starting apparently successful chemotherapy. The survival of these patients is compared with 56 other patients who did not have a second laparotomy but appeared to be responding to chemotherapy equally well. Survival advantage was seen for those who had a partial remission followed by a further debulking procedure later. However, those patients who have a clinical complete remission do not seem to benefit from a second surgical intervention.

Entities:  

Mesh:

Year:  1985        PMID: 3994934     DOI: 10.1111/j.1471-0528.1985.tb01359.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  2 in total

1.  Surgical procedures for ovarian cancer.

Authors:  J H Shepherd; M E Crowther; B G Ward; P Singh
Journal:  Ann R Coll Surg Engl       Date:  1986-11       Impact factor: 1.891

2.  The role of chemotherapy including ifosfamide for ovarian carcinoma. Austrian Collab. Ovarian Cancer Study Group.

Authors:  K Karrer; H Salzer; P Sevelda; C Dittrich
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.